Parts Catalog

All of the parts created and documented over the course of the project are on this page. Below is a table of parts added to the registry. All parts seen here have been engineered by the Virginia iGEM Team using components of publicly-available antibody sequences.

plasmid window

Parts Table

We added a total of ten basic parts (BBa_K4477001-BBa_K4477010) and four composite parts (BBa_K4477011-BBa_K4477014) to the registry.

Basic Parts

Part Number Type Description Designers Length
BBa_K4477001 Coding, Anti-oxLDL IgG Light Chain This sequence codes for the light chain of an anti-apoB(MDA) immunoglobulin G (IgG), an Orticumab-biosimilar antibody Miranda Khoury 654 bp
BBa_K4477002 Coding, Anti-oxLDL IgG Heavy Chain This sequence codes for the heavy chain of an anti-apoB(MDA) immunoglobulin G (IgG), an Orticumab-biosimilar antibody Miranda Khoury 1338 bp
BBa_K4477003 Coding, IK17 Anti-oxLDL scFv Antibody This sequence codes for a short chain variable fragment (scFv) derived from the anti-oxLDL IK17 antibody. Specifically, this scFv targets a protein structure called MDA-modified apo-B (apoB(MDA)) that is part of an oxLDL molecule. Miranda Khoury 795 bp
BBa_K4477004 Coding, McPC603 Anti-oxLDL scFv Antibody This sequence codes for a short chain variable fragment (scFv) derived from the anti-oxLDL McPC603 antibody, which targets oxidized phosphocholine on oxLDL. Miranda Khoury 798 bp
BBa_K4477005 Coding, Anti-mouse Camelid VHH Antibody This sequence codes for a VHH region antibody fragment, also referred to as an nanobody. It binds to the constant chain region of mouse-derived IgGs. Miranda Khoury 408 bp
BBa_K4477006 RBS, Orticumab-Biosimilar Light Chain expression RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of an IgG light chain for an anti-oxLDL antibody we designed (BBa_K4477001). Miranda Khoury 27 bp
BBa_K4477007 RBS, Orticumab-Biosimilar Heavy Chain expression RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of the heavy chain of our Orticumab biosimilar (anti-oxLDL) antibody (BBa_K4477002). Miranda Khoury 26 bp
BBa_K4477008 RBS, IK17 scFv expression RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of one of our designed IgG heavy chains (BBa_K4477003). Miranda Khoury 30 bp
BBa_K4477009 RBS, McPC603 scFv expression RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of one of our designed scFvs (BBa_K4477004). Miranda Khoury 31 bp
BBa_K4477010 RBS, VHH expression RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of one of our designed VHH antibody fragments (BBa_K4477005). Miranda Khoury 39 bp

Composite Parts

Part Number Type Description Designers Length
BBa_K4477011 Composite, Orticumab-biosimilar Anti-human oxLDL Complete Expression Cassette This sequence codes for a full IgG anti-apoB(MDA). It is derived partially from Orticumab, a human antibody that is currently in development. Miranda Khoury 2186 bp
BBa_K4477012 Composite, IK17 scFv Anti-oxLDL Complete Expression Cassette TThis sequence codes for a short chain variable fragment (scFv) derived from the anti-oxLDL IK17 antibody, which binds to MDA-modified apolipoprotein B on oxLDL. Miranda Khoury 988 bp
BBa_K4477013 Composite, McPC603 scFv Anti-oxLDL Complete Expression Cassette This sequence codes for a short chain variable fragment (scFv) derived from the anti-phosphocholine McPC603 antibody, which binds to oxidized phosphocholine on oxLDL. Miranda Khoury 992 bp
BBa_K4477014 Composite, Anti-mouse Camelid VHH Antibody Complete Expression Cassete This sequence codes for a heavy chain variable fragment (VHH), also known as a nanobody, that binds to the Fc region of murine IgGs. Miranda Khoury 610 bp